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Abstract 
Delirium occuring in patients with dementia is referred to as delirium superimposed on dementia 
(DSD). People who are older with dementia and who are institutionalized are at increased risk of 
developing delirium when hospitalized. In addition, their prior cognitive impairment makes 
detecting their delirium a challenge. The DSM-5 and the ICD-10 are considered the standard 
reference for the diagnosis of delirium and include criteria of impairments in cognitive processes 
such as attention, additional cognitive disturbances, or altered level of arousal. Neither the DSM-5 
nor the ICD-10 provides guidance regarding specific tests for assessment of the cognitive process 
impaired in delirium.   Importantly, the assessment or inclusion of pre-existing cognitive 
impairment is also not addressed by these standards.  The challenge of DSD gets more complex as 
types of dementia, particularly Dementia with Lewy Bodies, which has features of both delirium 
and dementia, are considered. The objective of this manuscript is to critically review key elements 
for the diagnosis of DSD including: the challenge of neuropsychological assessment in dementia 
patients; the influence of particular tests used to diagnose DSD. To address the challenges of DSD 
diagnosis, we present a framework for guiding the focus of future research efforts to develop a 
reliable reference standard to diagnose DSD.  A key feature of a reliable reference standard will 
improve the ability to clinically diagnose DSD in facility-based patients and research studies. 
 
 
  
 3 
Introduction 
 Delirium is an acute neuropsychiatric disorder characterized by a disturbance in attention 
and awareness, which develops over a short period of time, with additional disturbance in cognition 
which are not explained by a pre-existing cognitive impairment. Delirium that occurs in patients 
with dementia is referred to as delirium superimposed on dementia (DSD).1 People who 
are older with dementia and who are institutionalized are at increased risk of developing delirium 
when hospitalized. In addition, their prior cognitive impairment makes detecting their delirium a 
challenge.  The prevalence of DSD in institutionalized patients ranges from 1.4% to 70% according 
to the diagnostic tools,2 while the prevalence in community and hospital populations ranges from 
22% to 89%.1 It is associated with higher health care costs, worse functional outcomes, and higher 
mortality rates when compared to patients with dementia alone.1, 3-6 It was estimated that 35.6 
million people lived with dementia worldwide in 2010, with the prevalence expected to nearly 
double every 20 years, to 65 million in 2030 and 115 million in 2050.7 Therefore, DSD by inference 
will affect millions of people worldwide especially in nursing home facilities.  
 The diagnosis of delirium currently relies on the diagnostic criteria of the Diagnostic and 
Statistical Manual of Mental Disorders-5 (DSM-5) and the International Classification of Disease-
10 (Table 1).8, 9 These two standard references are similar in the definition of delirium, but it should 
be noted that no specific criteria are provided to clinicians or researchers in either system to assist 
with the diagnosis of DSD. The DSM-5 specifies that the cognitive deficits should not be better 
explained by a pre-existing, established or evolving neurocognitive disorder. In the ICD-10 pre-
existing cognitive deficits are not considered. 
 Thirty  years ago Lipowski provided a reference work for the definition of the concept of 
delirium.10 During the following years several terms have been used to define delirium. There has 
been an attempt to reduce the heterogeneity of delirium terminology to avoid “confusion” in clinical 
work and especially in research studies. The challenge to achieve clarity is even greater when 
delirium is considered in patients with preexisting dementia. In this context several terms have been 
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used: sundowning, acute dementia, rapidly progressive dementia, acute confusion, delirium in 
cognitively impaired patients, and delirium superimposed on dementia.11  
 While dementia may have more consistent terminology, the breadth of cognitive 
impairments in dementia nonetheless makes the assessment of baseline (and incident changes) in 
cognitive function challenging.  While some advocates prefer standardized testing, the progressive 
nature of dementia limits the battery of tests available.  Additionally, the growing diversity of the 
world population and the increasing challenge of dementia worldwide necessitate the availability of 
assessments in languages other than English.  
 The lack of standardization in the assessment of DSD may have potential significant clinical 
and research implications. Neither the DSM-5 nor the ICD-10 provide clinicians with indications of 
specific tests for assessment of attention or additional cognitive disturbances in cognition or altered 
level of arousal.  Importantly, the assessment or inclusion of pre-existing cognitive impairment is 
also not addressed by either the DSM-5 or ICD-10.  Meagher and colleagues have recently 
attempted to provide a standardized approach to the use of the DSM-5 criteria for delirium to avoid 
“confusion” even with the use of the standard reference.12   
 As the DSM-5 and the ICD-10 are considered the standard reference for the diagnosis of 
delirium, then several practical limitations should be considered. 
 First, attention has multiple domains13 and there is not a clear  DSM-5 and ICD-10 guidance 
regarding which domain or attention test should be used in patients with dementia, dementia stage, 
or dementia subtypes.  
 Second, the clinician is currently not provided with clear and predetermined methodology 
for how to ascertain the time of onset of delirium, the change from baseline, and fluctuation over 
the course of the day.  
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  Third, there is no reference for how to determine the presence of a pre-existing 
neurocognitive disorder or the level of arousal.  
 As a result, we formed a task force of EDA (European Delirium Association; 
www.europeandeliriumassociation.com), ADS (American Delirium Association; 
www.americandeliriumsociety.org), and AADA (Australasian Delirium Association; 
www.delirium.org.au) society members, collectively called iDelirium (www.idelirium.org), to a) 
clarify the key elements for the diagnosis of DSD, b) review evidence of DSD diagnosis, and c) 
formulate a path for the future direction of research in DSD.  
1. The challenge of neuropsychological assessment of delirium in dementia patients 
1.a) Attention deficits 
Inattention is considered a core feature of delirium (Criterion A, DSM-5) and a valid assessment of 
attention is therefore central to the diagnosis.  
Definition of attention 
Attention is widely studied in neuropsychology but there is not a single definition. A possible 
definition proposed by Cohen is the “ability to focus on a selected stimulus, sustaining that focus 
and shifting it at will.” 14 Three major functions of attention are (a) orienting to sensory events, (b) 
detecting signals for focal processing, and (c) maintaining a vigilant or alert state.13, 15 These are 
reflected to some extent in the DSM-5 criteria for delirium, which state that patients must 
demonstrate a 'reduced ability to direct, focus, sustain and shift attention.8 However, elements of 
executive function fall under the umbrella name of inattention and include much higher level 
cognitive tasks that are likely to be impaired in dementia such as shifting and divided attention 
(multitasking).   
Attentional deficits in delirium and dementia 
The extent to which different aspects of attention are affected in delirium is poorly understood. 
Marked impairments in focusing and sustaining attention (i.e. the ability to maintain attention to 
stimuli over time) are considered the hallmark feature of delirium.16-18 One of the key challenges of 
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delirium diagnosis is that the severity of attentional deficits in delirium varies greatly between 
patients (and also sometimes within the same patient at different time points), ranging from subtle 
impairments in complex working memory tasks, to more pronounced deficits in orienting and 
focusing attention, and finally to a state of lowered level of arousal whereby patients are unable to 
respond to simple commands. DSM-5 does not offer some guidance, as it states that an inability to 
engage in  standardized testing or interview should be classified as severe inattention.19  
  Complex attentional impairments may be found in the early stages of Alzheimer's Disease 
(AD) dementia (without delirium), but overall the ability to focus and sustain attention is relatively 
preserved in the earlier stages of AD.20 Conversely it has been shown that sustained, divided and 
selected attention are compromised in the moderate to severe stages of dementia.21 The type of 
dementia is also a factor.  For example, patients with Lewy Body dementia have considerably 
greater impairment of attention compared to patients with another type of dementia.22 Given the 
centrality of inattention to the definition of delirium, much more needs to be learned about the 
nature of attentional deficits in both dementia and delirium if criteria for the diagnosis of DSD are 
to be optimized.  
 Tests to evaluate inattention  
There is no consensus on  how attention should be assessed,23 and most existing tests differentiate 
the inattention found in delirium from that in dementia.24, 25   This uncertainty impedes progress in 
clinical practice and research. Several neuropsychological tests are currently used to assess 
inattention in delirium including digit span, spatial span, months of the year and days of the week 
backwards, and serial sevens.18 A recent review of studies on attention assessment in delirium 
concluded that cancellation tests (i.e., test to determine an individual’s ability to detect targets 
amongst a range of similar stimuli, usually digits or letters), span tests and computerized tests of 
sustained attention appear to offer utility in discriminating delirium from dementia.18 Months of the 
year backwards, one of the most widely used attention test in clinical practice, appears to have high 
sensitivity to delirium in older hospitalized patients.26-28   
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 In general, caution is warranted when generalizing these findings. Further, tests are often 
labeled as measuring inattention when they also depend on other cognitive components, which 
themselves are more likely to be affected in dementia. There is an overlap of attention, working 
memory, and executive control. For instance, digit span is used as a measure of inattention but it is 
also used to measure executive functiong and working memory. Cognitively simple tests that rely 
on focusing and sustaining attention rather than manipulating information or testing memory may 
be especially useful in discriminating delirium from dementia. For instance, in preschool children 
attention deficits have been evaluated moving slowly a simple picture in front of the patient’s face 
while verbally prompting them to look at the picture and evaluating their ability to look at the 
pictures when their eyes are open.29  
1.b) Arousal, awareness and motor fluctuations 
Different cognitive domains are affected in dementia. For example, while the ability to learn is 
reduced, an individual may still have little difficulty with perceptual motor functioning, and perhaps 
be slightly less impaired in selective attention in comparison to the ability to divide attention. 
Clearly the ability to engage cognition depends on the degree of arousal (Figure 2). The term 
“arousal” can be defined as the level of sensory stimulation that is required to keep the patient 
attending to the examiner’s question or following a command. 30  
The key role of arousal in delirium was first recognized over three decades ago and is now 
well established. In 1980 the Diagnostic and Statistical Manual of Mental Disorders (DSM) III 
version indicated that impaired consciousness was a core symptom of delirium, and this criterion 
was confirmed in subsequent years by almost all the classification systems. In what seems to be a 
reversal in this guidance, the current DSM-5 places greater emphasis on awareness, attention, and 
other cognitive disorders while de-emphasizing consciousness .8 Indeed, Criterion D of DSM-5 
criteria state that inattention and changes in cognition must not occur in the context of a severely 
reduced level of arousal such as coma. Far from being a downgrading of the role of arousal in 
delirium, these criteria implicitly admit that arousal disorders are an integral aspect   of this 
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condition.31 In fact, both attention and arousal are hierarchically related: it is possible to have full 
arousal, but profound inattention (for example, hypervigilance), but not the other way around, 32 
(i.e., when disorders of arousal exist inattention is always present).31 In other words, the DSM-5 
criteria identify a threshold (i.e., coma) under which a patient cannot be regarded as delirious, but 
does not reject the role of arousal in delirium phenomenology. 31  
Leonard and colleagues33 have reported that delirium may be distinguished from dementia 
by virtue of the disproportionate impairment of vigilance and attention. Importantly, arousal is 
generally preserved in advanced chronic cognitive disorders,16 while attention and cognition (i.e., 
orientation, memory, language and executive functions) are usually already impaired in the 
moderate stages of dementia 26, 34 and especially when dementia is severe.35 A pathophysiological 
explanation relies on evidence that performance on attentional and general cognitive tasks, when 
administered, is contingent on brain activity in distributed cortical areas36 which are generally 
damaged in the advanced stages of dementia, while arousal assessment tests structures in the 
brainstem.37 Because the hierarchical pattern of neurodegeneration in Alzheimer’s disease begins in 
the entorhinal/perirhinal cortex, then progresses in the hippocampus and in association cortex, and 
finally in the primary neocortex (NIA-RI Consensus 1997), it could be hypothesized that attentional 
and other cognitive tasks can  not be assessed when the damage in the brain is advanced. On the 
contrary, arousal assessment may be feasible  when dementia is severe. To indirectly support this 
observation, it is not surprising that studies to discriminate neuropsychological profiles of delirious 
and demented patients have generally recruited individuals with mild or, at most, moderate stages of 
dementia.  
Tieges and colleagues developed a new approach with the Observational Scale of Level of 
Arousal OSLA38, to detect delirium by observing eye opening,  eye contact, as well as patient  
posture and movement. Delirium is not an isolated mental disorder, but affects motor function as 
well.39, 40 The evaluation of posture and movement might indeed be of interest in the context of 
patients with dementia. A study comparing 4 groups of 15 patients (with delirium alone, with 
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dementia alone, with delirium superimposed on dementia and with neither delirium nor dementia) 
found that when delirium develops, a worsening of motor performance also  occurs. 40 In patients 
with pre-existing dementia, the resolution of delirium did not result in a significant improvement of 
specific cognitive functions, providing indirect evidence that when dementia is advanced, the 
cognitive testing does not provide good information to support the diagnosis of delirium. In this 
case, an assessment of motor abilities may assume a more specific diagnostic utility. 40  
 In this regard, the Richmond Agitation and Sedation Scale (RASS),41, 42 a scale originally 
evaluated to monitor the level of consciousness in critically ill patients, might provide important 
information on motor fluctuations given its potential to identify motor subtypes of delirium. 
Negative scores on the  RASS may indicate hypoactive behavior in delirium, and a positive scores 
indicative of a hyperactive behavior. The scale has been recently modified and adapted for use in 
general wards (i.e. the modified RASS or m-RASS). 43 Both the RASS and the m-RASS are ultra-
brief assessments of the level of consciousness and recent studies have suggested that they have 
high specificity for delirium in geriatrics wards, emergency department38, 43, 44 and specifically in 
patients with dementia.45  
It could therefore be hypothesized that when dementia is severe or very severe, and attention 
cannot be tested using tools that require a certain level of cognition, arousal and basic motor 
performance may be routinely assessed to detect delirium. For example, the observation of an 
unexpected drowsiness or failure to sit up from the bed in patients who were previously alert and 
able to move could suggest delirium in demented patients. Mobility performances in patients with 
dementia may similarly be used to detect incipient delirium.  
2. Dementia with Lewy bodies and the influence on tests used to diagnose delirium 
The clinical phenotypes of dementias show some overlap with delirium.  For example, fluctuating 
cognition is seen in Alzheimer’s disease and vascular dementia; however the prevalence and 
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severity of fluctuation is greatest in dementia with Lewy bodies (DLB).46 Similarly, complex visual 
hallucinations and delusions frequently occur in DLB, Parkinson’s disease dementia (PDD) and 
delirium , but are seen in only 4-8% of AD patients.47 As a result, it is harder to differentiate DLB 
from delirium in comparison to other dementias according to the key features as identified by 
Meagher et al (attentional deficits, sleep-wake cycle disturbance, impaired higher level thinking 
disturbances).48 DLB is viewed by many as the most challenging dementia subtype in which to 
diagnose DSD.49   
There is a pressing need to develop methods to distinguish delirium and DLB.  Lewy Body 
disease is the second most common form of dementia in older people with a prevalence of 15-20% 
of all dementias at autopsy.50 The prevalence of older adults with two or more DLB symptoms in 
nursing homes ranges from 16% to 20%.51 Furthermore DLB patients also appear to be more 
acutely sensitive to minor insults (even subclinical events) and thus more delirium “prone”.  
Consequently, and unsurprisingly, delirium is more commonly diagnosed in DLB than Alzheimer’s 
dementia (AD)52 with 32% of outpatients with DLB experiencing delirium as opposed to 15% of 
outpatients with AD.53  
Differentiating DSD from DLB or delirium alone is vital in order to guide initial 
management and safe prescribing.  Incorrectly diagnosing an acute change as a deterioration in 
patients with existing DLB rather than delirium can result in the under-investigation of common 
causes of delirium such as infections, medications and pain and inadequate management of this 
potentially life threatening medical emergency.  Conversely, the lack of recognition of undiagnosed 
DLB in someone with delirium may result in patients being treated with anti-psychotic medications. 
Such agents can significantly worsen features of their DLB, such as parkinsonism and cognitive 
impairment/arousal, and significantly increase the risk of mortality.54   Furthermore, a failure to 
diagnosis DLB may mean that patients receive treatments such as cholinesterase inhibitors, which 
have been shown to improve hallucinations, delusions and cognition in patients with DLB.55 Given 
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findings that suggest cholinesterase inhibitors might worsen delirium outcomes,56 it is imperative 
that  an accurate diagnoses of DLB in these settings. 
Because of these overlapping clinical phenotypes, collateral history is essential to the 
identification of delirium in patients with DLB; what is sought is whether there is a recent history of 
a significant or acute change in behavior.  Clinicians need to be vigilant to an acute, distinct change 
compared to baseline, including increased fluctuations in someone who previously had 
predominantly Parkinsonism and hallucinations.  In those with delirium, a previous history of 
symptoms including autonomic dysfunction (i.e., recurrent dizziness, blackouts, constipation, 
urinary urgency etc.), REM sleep behaviour disorder, anosmia, visuoperceptual disturbances as well 
as psychosis and episodes of delirium, along with clinical examination findings of Parkinsonism 
(e.g. bradykinesia, hypomimia, tremor, rigidity, change in posture, recurrent falls or altered gait), 
may all suggest an undiagnosed DLB.  The best methods to elicit these collateral histories may 
provide a focus for future diagnostic work to assist with the diagnosis of delirium in patients with 
DLB. 
Research into how to recognize delirium in people with DLB may also focus on developing 
methods to test features that are most likely to differ, including cognitive domains such as 
orientation, vigilance and psychomotor disturbances.50 Currently, when there is a suspicion of DLB, 
diagnostic biomarkers such as a DaT SCAN may be helpful,57 although from a practical point of 
view, these usually need to be performed after the delirium episode ends.  The role of objective 
biomarkers measurements such as electroencephalography (EEG) to distinguish delirium and DLB, 
is appealing, however EEG patterns in delirium overlap with those seen in DLB, making the 
differentiation more difficult. More advanced methods of EEG processing/quantification may 
illuminate other specific nuances between delirium and DLB and could provide a focus for future 
research. 
3. Framework for improving the diagnosis of DSD 
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There are many gaps in our knowledge about how to diagnose DSD with a high degree of accuracy. 
The current state of the science does not provide guidance on which clinical tests and biomarkers 
should be specifically tested in DSD patients. Additional challenges are related to the possible 
difference in DSD presentation in patients with different types of dementia (Figure 1). 
Here we provide a consensus from the iDelirium group on research that is needed to   clarify 
important key points in the diagnosis of DSD (Table 3).   
Improving Attention testing 
1) Define which types of attention should be tested ; 2) Define what type of attention should be 
tested according to the type of dementia and severity of dementia ; 3) Define what attention tests 
should be used according to the type of dementia and severity of dementia.    
Impact of arousal/awareness/motor fluctuations 
1) Further define the implications  for using the RASS, m-RASS, or OSLA to  diagnosis DSD and 
the  possible implications on outcomes; 2) Define the role of the use of objective evaluation of the 
level of motor fluctuation (e.g., actigraphy monitoring) for  the diagnosis of DSD; 3) Define the 
importance and the possible use of clinical evaluation of motor fluctuation using bed-side tests (e.g. 
Tinetti scale, Hierarchical Assessment of Balance and Mobility). 
Clinical evaluation of DSD 
Define a specific protocol to collect information from family members, review of medical records,  
to determine basic and instrumental activities of daily living, and to determine  prior cognitive 
function using a standardized collateral informant questionnaire such as the the SF-IQCODE or the 
AD8.  
Clinical exam  
Define which component of the neurological exam might be useful or indicative in the diagnosis of 
DSD e.g., tendon reflexes, plantar reflexes, UPM/extrapyramidal, archaic reflexes, myoclonia; eye 
examination including pupil size, light reflex, oculocephalic response; cough reflex, grimace. 
Laboratory testing  
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1) Define a core set of laboratory evaluation for the clinical diagnosis of DSD; 2) Define a core set 
of laboratory evaluation for the research diagnosis of DSD 
Neuroimaging  
1) Clarify the role of neuroimaging in the clinical diagnosis of DSD 
2) Provide indications for the use of neuroimaging techniques for a research standard of diagnosis 
of DSD (e.g., brain MRI, DaT SCAN) 
Summary   
Delirium superimposed on dementia is a clinical syndrome that can result in very poor outcomes.  
Accurate identification has so far been elusive.  In this report, we have presented descriptions of its 
presentation and associated clinical findings, and the insufficiency of current diagnostic assessment 
tools.  We hope that our framework will be helpful for the improved delineation of this highly 
problematic geriatric clinical syndrome.  
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Table 1: DSM-5 and ICD-10 diagnosis of delirium 
 DSM-5 ICD-10 
Attention Disturbance in ability to direct, focus, 
sustain, or shift  
     and  
Reduced ability to focus, sustain, or 
shift attention. 
Awareness Disturbance in awareness 
environmental orientation 
 
Clouding of consciousness, that is, 
reduced clarity of awareness of the 
environment 
Timing / 
Fluctuation 
Develops quickly (hours to days) and 
represents a change from baseline 
and fluctuates over a day 
 
Rapid onset and fluctuations of the 
symptoms over the course of the day. 
 
Memory 
Deficit 
An additional disturbance in 
cognition (e.g. memory deficit, 
disorientation, language, visuospatial 
ability, or perception). 
Disturbance of cognition, manifest by 
both: (1) impairment of immediate 
recall and recent memory, with 
relatively intact remote memory; (2) 
disorientation in time, place, or person. 
Psychomotor 
Deficit 
None?) 
 
At least one of the following 
psychomotor disturbances: (1) rapid 
unpredictable shifts from hypoactivity to 
hyperactivity; (2) increased reaction 
time; (3) increased or decreased flow of 
speech; (4) enhanced startle reaction. 
Sleep 
Disturbance 
None Disturbance of sleep or the sleep/wake 
cycle, manifest by at least one of the 
following: (1) insomnia, which in severe 
cases may involve total sleep loss, with 
or without daytime drowsiness, or 
reversal of the sleep/wake cycle; (2) 
nocturnal worsening of symptoms; (3) 
disturbing dreams and nightmares that 
may continue as hallucinations or 
illusions after awakening. 
Corroborating 
Data 
There is evidence from the history, 
physical examination or laboratory 
findings that the disturbance is a 
direct physiological consequence of 
another medical condition, substance 
intoxication or withdrawal, or 
exposure to a toxin, or is due to 
multiple etiologies. 
 
Objective evidence from history, 
physical and neurological examination, 
or laboratory tests of an underlying 
cerebral or systemic disease (other than 
psychoactive substance-related) that can 
be presumed to be responsible for the 
clinical manifestations.  
 15 
Other 
Cognitive 
Disorders 
Not better explained by a pre-
existing, established or evolving 
neurocognitive disorder and do not 
occur in the context of a severely 
reduced level of arousal, such as 
coma. 
None 
 
 
  
 16 
Table 2: Delirium and Dementia with Lewy bodies: overlap and differences 
Delirium Dementia with Lewy bodies (DLB) 
Onset: Acute onset Onset: Gradual and progressive onset 
Cognitive impairment: fluctuation in 
attention, executive functioning, memory, 
visuospatial deficits 
Cognitive impairment: fluctuation in attention, 
executive functioning, vigilance, memory, 
visuospatial deficits 
Perceptual disturbances: visual and 
auditory hallucinations, delusions  
Perceptual disturbances: recurrent structured visual 
hallucinations, delusions 
Sleep wake-cycle: disturbance in sleep 
wake-cycle 
Sleep wake-cycle: REM sleep behavior disorder 
Motor signs: hyperactive or hypoactive 
motor signs 
Motor signs: parkinsonism motor signs 
Neuroleptic sensitivity: non present Neuroleptic sensitivity: severe neuroleptic 
sensitivity 
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Table 3: Framework for improving the diagnosis of delirium superimposed on dementia 
(DSD).  
   
Improving attention testing 1) Define what type of attention should be tested  
2) Define what type of attention should be tested according to the 
type of dementia and severity of dementia  
3) Define what attention test should be used according to the type of 
dementia and severity of dementia 
Impact of 
arousal/awareness/motor 
fluctuations 
1) Further define the implication on the use of the RASS, m-RASS, 
OSLA on the diagnosis of DSD and their possible implications on 
outcomes 
2) Define the role of the use of objective evaluation of the level of 
motor fluctuation (e.g., actigraphy monitoring) on the diagnosis of 
DSD 
3) Define the importance and the possible use of clinical evaluation 
of motor fluctuation using bed-side tests (e.g. Tinetti scale, 
Hierarchical Assessment of Balance and Mobility) 
Clinical evaluation of DSD Define how clinicians should test DSD using clinical information 
collected from family members, medical record review, evaluation of  
basic and instrumental activities of daily living 
Clinical exam  Define which component of the neurological exam might be useful or 
indicative in the diagnosis of DSD 
Laboratory testing  1) Define a core set of laboratory evaluation for the clinical diagnosis 
of DSD 
2) Define a core set of laboratory evaluation for the research 
diagnosis of DSD 
Neuroimaging 1) Clarify the role of neuroimaging in the clinical diagnosis of DSD 
2) Provide indications on which neuroimaging techniques could be of 
use in the research diagnosis of DSD (e.g., brain MRI, DaT SCAN) 
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Figure 1: The challenge of delirium across different types of dementia and possible overlap with 
behavioral and psychological symptoms of dementia (BPSD). AD (Alzheimer’s dementia), VaD 
(vascular dementia), PD (Parkinson dementia), DLB (dementia with Lewy bodies). 
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Figure 2: Cognitive domains and arousal. Different cognitive domains are affected in dementia. 
but the ability to engage cognition depends on the degree of arousal. In the radar plot to the left of 
the figure this particular individual has almost normal arousal, perhaps being somewhat hyperalert 
(dashed circle signals “normal” arousal). With the onset of delirium, most cognitive domains 
deteriorate as arousal decreases (degree of arousal=dotted red circle) – as could be the case given 
hypoactive delirium (radar plot to the right). In this constellation of an individual having shown 
cognitive impairment – including attention – prior to delirium, it is especially challenging to 
adequately test for specific change in any one of multiple attentional domains (marked 1). It is, 
moreover, as difficult to determine the time of onset given that change is not from a non-impaired 
state (marked 2; the solid black line on the timeline signals the fluctuating degree of cognitive 
impairment, in close relationship to the severity of delirium symptoms), not knowing how severe 
the baseline impairment (dotted red line on the timeline) actually was (marked 3). 
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